Vývoj doporučení pro použití venofarmak v léčbě chronického žilního onemocnění - kde je jejich místo a kde jsou slabiny
[Development of recommendations for the use of venoactive drugs in the treatment of chronic venous disease - where they are effective and where they are not]
Language Czech Country Czech Republic Media print
Document type Journal Article
PubMed
36220421
PII: 131972
- Keywords
- GRADE, Randomized controlled trials, level of evidence, pentoxifylline, strenght of recommendation, sulodexide, symptomatic treatment, venoactive drugs,
- MeSH
- Chronic Disease MeSH
- Lower Extremity MeSH
- Humans MeSH
- Microcirculation MeSH
- Varicose Veins * diagnosis drug therapy MeSH
- Venous Insufficiency * drug therapy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
The article provides an overview of the development of recommendations for indications of venoactive drugs for treating symptoms and signs associated with chronic venous disease (CVD). Venoactive drugs may be beneficial in patients with subjective problems and/or swelling of the lower limbs, after surgery for varicose veins, in chronic venous insufficiency or in microcirculatory disorders. They are not indicated in asymptomatic patients with CVD, in the prevention of varicose veins or to prevent their progression. Drugs with proven efficacy in clinical trials should be preferred.